Latest filing published 28 Sept 2023 for Peak Bio, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Stephen J. LaMond: trading record in brief
This profile gathers the share dealings of Stephen J. LaMond in Peak Bio, Inc. Between 15 September 2023 and 27 September 2023, the trades on record add up to 6 filings.
The open-market record is one-sided, with 6 purchases and not one sale. No amount is published for 6 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
No cluster: in 3 purchases, no other insider of the company bought within 30 days.
The newest entry dates from 28 September 2023: an open-market purchase, in Peak Bio, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Stephen J. LaMond
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500 sharesCommon StockSEC:0000950170-23-050434:1Canonical exit: 17 Dec 2023 (T+90)
- 2,600 sharesCommon StockSEC:0000950170-23-050436:1Canonical exit: 26 Dec 2023 (T+90)
- 11,750 sharesCommon StockSEC:0000950170-23-050434:0Canonical exit: 14 Dec 2023 (T+90)
- 3,000 sharesCommon StockSEC:0000950170-23-050436:0Canonical exit: 25 Dec 2023 (T+90)
- 2,500 sharesCommon StockSEC:0000950170-23-048775:1Canonical exit: 17 Dec 2023 (T+90)
- 26,000 sharesCommon StockSEC:0000950170-23-048775:0Canonical exit: 14 Dec 2023 (T+90)
6 of 6 declarations